<?xml version="1.0" encoding="utf-8"?>
<item href="/news/in-the-media/2024/articles/1723663550.php" dsn="blogs">
  <type>external</type>
  <image>
    <img src="https://newhaven.edu/_resources/images/faculty-staff-headshots/karl-minges.png" alt="Karl Minges"/>
  </image>
  <category>In the Media</category>
  <image-caption/>
  <title>Voice of America: Biden strikes $150M blow against cancer in campaign to slash deaths</title>
  <pubDate>August 14, 2024</pubDate>
  <description>Karl Minges, an assistant professor of public health, says about Cancer Moonshot, 'By giving the money to the institutes, it's sort of available as public funding for researchers to access, and anytime that's the case, there's an imperative, whether it's a clinical trial or it's a an observational study, that the results are in the public domain, so that can be then subsumed by other countries outside of the United States who face similar issues.'</description>
  <hide-description/>
  <external_link>https://www.voanews.com/a/biden-strikes-150m-blow-against-cancer-in-campaign-to-slash-deaths-/7741602.html</external_link>
  <hide-description/>
  <author>karl-minges</author>
  <author-details/>
  <hide-author/>
  <image-caption/>
  <hide-image/>
  <tags>
    <tag>news-all</tag>
    <tag>news-in-the-media</tag>
    <tag>year-2024</tag>
    <tag>month-august</tag>
    <tag>name-karl-minges</tag>
  </tags>
</item>
